Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3Thoracic 1Gastrointestinal 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2Solid Tumors 1

Interventions

Cisplatin 70Paclitaxel 68pembrolizumab 65Carboplatin 61Irinotecan 59Injections 53Gemcitabine 53Docetaxel 49Fluorouracil 35Cyclophosphamide 35Pemetrexed 34Oxaliplatin 31Capecitabine 30Bevacizumab 29Leucovorin 27atezolizumab 23Nivolumab 23tislelizumab 19Etoposide 18Cetuximab 17durvalumab 16Temozolomide 16Bortezomib 16alvocidib 15Topotecan 15olaparib 14Sorafenib 14Rifampin 14Itraconazole 14Erlotinib Hydrochloride 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Endostatins × Other solid neoplasm × Clear all
NCT00004872 2019-12-13

Endostatin in Treating Patients With Advanced Refractory Solid Tumors

University of Wisconsin, Madison

Phase 1 Completed
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004229 2013-02-11

Endostatin in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00165373 2007-12-28

rhEndostatin Protein Involving Pediatric Patients With Cancer

Dana-Farber Cancer Institute

Phase 1 Terminated
21 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡